Cargando…
Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center
OBJECTIVE: To evaluate the prevalence, risk factors, and clinical impact of delays in second doses of antibiotics in patients with sepsis. DESIGN: Single-center, retrospective, observational study. SETTING: Large teaching hospital. PATIENTS: Adult patients who triggered an electronic sepsis alert in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654957/ https://www.ncbi.nlm.nih.gov/pubmed/38028903 http://dx.doi.org/10.1017/ash.2023.480 |
_version_ | 1785136722227494912 |
---|---|
author | Cook, Meghan E. Schuler, Brian R. Schontz, Michael J. McLaughlin, Kevin C. Lupi, Kenneth E. DeGrado, Jeremy R. Rhee, Chanu |
author_facet | Cook, Meghan E. Schuler, Brian R. Schontz, Michael J. McLaughlin, Kevin C. Lupi, Kenneth E. DeGrado, Jeremy R. Rhee, Chanu |
author_sort | Cook, Meghan E. |
collection | PubMed |
description | OBJECTIVE: To evaluate the prevalence, risk factors, and clinical impact of delays in second doses of antibiotics in patients with sepsis. DESIGN: Single-center, retrospective, observational study. SETTING: Large teaching hospital. PATIENTS: Adult patients who triggered an electronic sepsis alert in the emergency department (ED), received ≥2 doses of vancomycin or an antipseudomonal beta-lactam, and were discharged with an ICD-10 sepsis code. METHODS: We assessed the prevalence of delays in second doses of antibiotics by ≥25% of the recommended dose interval and conducted multivariate regression analyses to assess for risk factors for delays and in-hospital mortality. RESULTS: The cohort included 449 patients, of whom 123 (27.4%) had delays in second doses. In-hospital death occurred in 31 patients (25.2%) in the delayed group and 71 (21.8%) in the non-delayed group (p = 0.44). On multivariate analysis, only location in a non-ED unit at the time second doses were due was associated with delays (OR 2.75, 95% CI 1.20–6.32). In the mortality model, significant risk factors included malignant tumor, respiratory infection, and elevated Sequential Organ Failure Assessment (SOFA) score but not delayed second antibiotic doses (OR 1.19, 95% CI 0.69–2.05). In a subgroup analysis, delayed second doses were associated with higher mortality in patients admitted to non-intensive care units (ICUs) (OR 4.10, 95% CI 1.32–12.79). CONCLUSIONS: Over a quarter of patients with sepsis experienced delays in second doses of antibiotics. Delays in second antibiotic doses were not associated with higher mortality overall, but an association was observed among patients admitted to non-ICUs. |
format | Online Article Text |
id | pubmed-10654957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106549572023-11-10 Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center Cook, Meghan E. Schuler, Brian R. Schontz, Michael J. McLaughlin, Kevin C. Lupi, Kenneth E. DeGrado, Jeremy R. Rhee, Chanu Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVE: To evaluate the prevalence, risk factors, and clinical impact of delays in second doses of antibiotics in patients with sepsis. DESIGN: Single-center, retrospective, observational study. SETTING: Large teaching hospital. PATIENTS: Adult patients who triggered an electronic sepsis alert in the emergency department (ED), received ≥2 doses of vancomycin or an antipseudomonal beta-lactam, and were discharged with an ICD-10 sepsis code. METHODS: We assessed the prevalence of delays in second doses of antibiotics by ≥25% of the recommended dose interval and conducted multivariate regression analyses to assess for risk factors for delays and in-hospital mortality. RESULTS: The cohort included 449 patients, of whom 123 (27.4%) had delays in second doses. In-hospital death occurred in 31 patients (25.2%) in the delayed group and 71 (21.8%) in the non-delayed group (p = 0.44). On multivariate analysis, only location in a non-ED unit at the time second doses were due was associated with delays (OR 2.75, 95% CI 1.20–6.32). In the mortality model, significant risk factors included malignant tumor, respiratory infection, and elevated Sequential Organ Failure Assessment (SOFA) score but not delayed second antibiotic doses (OR 1.19, 95% CI 0.69–2.05). In a subgroup analysis, delayed second doses were associated with higher mortality in patients admitted to non-intensive care units (ICUs) (OR 4.10, 95% CI 1.32–12.79). CONCLUSIONS: Over a quarter of patients with sepsis experienced delays in second doses of antibiotics. Delays in second antibiotic doses were not associated with higher mortality overall, but an association was observed among patients admitted to non-ICUs. Cambridge University Press 2023-11-10 /pmc/articles/PMC10654957/ /pubmed/38028903 http://dx.doi.org/10.1017/ash.2023.480 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article Cook, Meghan E. Schuler, Brian R. Schontz, Michael J. McLaughlin, Kevin C. Lupi, Kenneth E. DeGrado, Jeremy R. Rhee, Chanu Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
title | Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
title_full | Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
title_fullStr | Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
title_full_unstemmed | Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
title_short | Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
title_sort | prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654957/ https://www.ncbi.nlm.nih.gov/pubmed/38028903 http://dx.doi.org/10.1017/ash.2023.480 |
work_keys_str_mv | AT cookmeghane prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter AT schulerbrianr prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter AT schontzmichaelj prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter AT mclaughlinkevinc prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter AT lupikennethe prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter AT degradojeremyr prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter AT rheechanu prevalenceriskfactorsandoutcomesassociatedwithdelayedseconddosesofantibioticsinsepsisatalargeacademicmedicalcenter |